[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-341259-en":59,"doc-seo-341259-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},341259,4398048950312,"Violet","https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies","Immune checkpoint inhibitors offer strong benefits for some cancers, but responses often concentrate in a limited group of patients with “hot” tumors. This review explains how the cGAS-STING pathway can recondition the tumor microenvironment by bridging innate and adaptive immunity, promoting type I interferon production and recruiting CD8+ T cells to convert “cold” tumors into “hot” ones. It details mechanisms, immune-cell contributions, and the newest clinical evidence for STING agonists, including combination-therapy directions and key translational challenges in clinical development.","TYPE Review  \nPUBLISHED 16 May 2024  \nDOI 10.3389/fimmu.2024.1399926  \nOPEN ACCESS  \nEDITED BY  \nAlejandro Lo´ pez-Soto, University of Oviedo, Spain  \nREVIEWED BY Mengze Lyu,  \nCornell University, United States Ankita Leekha,  \nUniversity of Houston, United States  \n*CORRESPONDENCE Wenlin Chen  \n [chenwenlin1@hotmail.com](chenwenlin1@hotmail.com)[ ](chenwenlin1@hotmail.com)Fei Ge  \n [ajqnadjd@hotmail.com](ajqnadjd@hotmail.com)  \n†These authors have contributed equally to this work  \nRECEIVED 12 March 2024  \nACCEPTED 26 April 2024  \nPUBLISHED 16 May 2024  \nCITATION  \nHuang M, Cha Z, Liu R, Lin M, Gafoor NA, Kong T, Ge F and Chen W (2024) Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment  \nvia combined cGAS-STING pathway strategies.  \nFront. Immunol. 15:1399926 .  \ndoi: 10.3389/fimmu.2024.1399926  \nCOPYRIGHT  \n© 2024 Huang, Cha, Liu, Lin, Gafoor, Kong, Ge and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nEnhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies  \nMingqing Huang 1†, Zhuocen Cha 1,2†, Rui Liu 3†, Mengping Lin 1, Naif Abdul Gafoor 4, Tong Kong 5, Fei Ge 6* and Wenlin Chen 1*  \n1Third Department of Breast Surgery, The Third Afﬁliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China, 2Guizhou Hospital of the First Afﬁliated Hospital, Sun Yatsen University, Guizhou, China, 3 Department of Breast Surgery, The Third Afﬁliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China, 4 International Education School of Kunming Medical University, Kunming, China, 5 Department of Gynecology, The Third Afﬁliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China,  \n6 Department of Breast Surgery, The First Afﬁliated Hospital of Kunming Medical University, Kunming, China  \nImmune checkpoint inhibitors (ICIs) represent a groundbreaking advance in the treatment of malignancies such as melanoma and non-small cell lung cancer, showcasing substantial therapeutic beneﬁts. Nonetheless, the efﬁcacy of ICIs is limited to a small subset of patients, primarily beneﬁting those with “hot” tumors characterized by signiﬁcant immune inﬁltration. The challenge of converting“cold” tumors, which exhibit minimal immune activity, into “hot” tumors to enhance their responsiveness to ICIs is a critical and complex area of current research. Central to this endeavor is the activation of the cGAS-STING pathway, a pivotal nexus between innate and adaptive immunity. This pathway’s activation promotes the production of type I interferon (IFN) and the recruitment of CD8+ T cells, thereby transforming the tumor microenvironment (TME) from “cold” to“hot”. This review comprehensively explores the cGAS-STING pathway ’s role in reconditioning the TME, detailing the underlying mechanisms of innate and adaptive immunity and highlighting the contributions of various immune cells to tumor immunity. Furthermore, we delve into the latest clinical research on STING agonists and their potential in combination therapies, targeting this pathway. The discussion concludes with an examination of the challenges facing the advancement of promising STING agonists in clinical trials and the pressing issues within the cGAS-STING signaling pathway research.  \nKEYWORDS  \ncGAS-STING, hot tumor, tumor immunology, immune checkpoint inhibitor (ICI), tumor microenvironment  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nTumor initiation, progression, and metasta","cbCaiqlZSVmoNzm8","https://ap.wps.com/l/cbCaiqlZSVmoNzm8","pdf",3618419,15,"English","en",105,"# Introduction\n## Tumor microenvironment and immune escape\n## Immune phenotypes: hot, cold, and immune-excluded/desert\n# cGAS-STING pathway as a nexus of innate and adaptive immunity\n## Type I interferon induction and CD8+ T-cell recruitment\n# Clinical research on STING agonists and combination strategies\n## Translational challenges and open issues in clinical trials","[{\"question\":\"Why are immune checkpoint inhibitors effective only for some patients?\",\"answer\":\"Their efficacy is largely limited to patients with “hot” tumors that show substantial immune infiltration and inflammatory signals.\"},{\"question\":\"How does the cGAS-STING pathway help convert “cold” tumors into “hot” tumors?\",\"answer\":\"Activation of cGAS-STING drives type I interferon production and promotes recruitment of CD8+ T cells, reshaping the tumor microenvironment toward a “hot” state.\"},{\"question\":\"What does the review cover regarding STING agonists?\",\"answer\":\"It summarizes the latest clinical research on STING agonists and discusses their potential use in combination therapies targeting the cGAS-STING pathway.\"}]","Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies | PDF",1790041174,38,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1086c04e3272fea5f559c5af9fb68b96.webp",983,1389,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e3f518430bd443a49859fd3dc6f2a42.webp",982,1388,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3474f9b12c0a5dd9ebf575d781b92840.webp",981,1386,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/044fbae8af6627e5f17d37ffe6c2e195.webp",980,1385,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"enhancing-immunotherapy-outcomes-by-targeted-remodeling-of-the-tumor-microenvironment-via-combined-cgas-sting-pathway-strategies","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/enhancing-immunotherapy-outcomes-by-targeted-remodeling-of-the-tumor-microenvironment-via-combined-cgas-sting-pathway-strategies/341259/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/enhancing-immunotherapy-outcomes-by-targeted-remodeling-of-the-tumor-microenvironment-via-combined-cgas-sting-pathway-strategies/341259.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":44},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"Why are immune checkpoint inhibitors effective only for some patients?","Question",{"text":146,"@type":147},"Their efficacy is largely limited to patients with “hot” tumors that show substantial immune infiltration and inflammatory signals.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How does the cGAS-STING pathway help convert “cold” tumors into “hot” tumors?",{"text":151,"@type":147},"Activation of cGAS-STING drives type I interferon production and promotes recruitment of CD8+ T cells, reshaping the tumor microenvironment toward a “hot” state.",{"name":153,"@type":144,"acceptedAnswer":154},"What does the review cover regarding STING agonists?",{"text":155,"@type":147},"It summarizes the latest clinical research on STING agonists and discusses their potential use in combination therapies targeting the cGAS-STING pathway.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790183353]